Compare CDP & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDP | LIVN |
|---|---|---|
| Founded | 1988 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.5B |
| IPO Year | 1996 | 2015 |
| Metric | CDP | LIVN |
|---|---|---|
| Price | $38.27 | $80.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $34.57 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 894.5K | 549.7K |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | ★ 8.94 | N/A |
| EPS | 0.34 | ★ 0.40 |
| Revenue | ★ $763,923,000.00 | N/A |
| Revenue This Year | $1.18 | $9.79 |
| Revenue Next Year | $3.71 | $6.63 |
| P/E Ratio | ★ $111.85 | $195.48 |
| Revenue Growth | ★ 1.41 | N/A |
| 52 Week Low | $26.91 | $41.02 |
| 52 Week High | $38.16 | $85.27 |
| Indicator | CDP | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 71.65 | 51.12 |
| Support Level | $30.73 | $61.63 |
| Resistance Level | N/A | $80.96 |
| Average True Range (ATR) | 0.62 | 2.31 |
| MACD | -0.02 | -0.62 |
| Stochastic Oscillator | 89.76 | 53.53 |
COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. The company has two reportable segments: Defense/IT Portfolio; and Other. Defense/IT Portfolio includes sub-segments such as: Fort George G. Meade and the Baltimore/Washington Corridor (Fort Meade/BW Corridor); Redstone Arsenal in Huntsville, Alabama; Northern Virginia Defense/IT Locations (NoVA Defense/IT); Lackland Air Force Base in San Antonio, Texas; locations serving the U.S. Navy (Navy Support); and data center shells in Northern Virginia.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.